Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGFβ Signaling in the Pancreatic Tumor Microenvironment
Daniel R. Principe, Kaytlin E. Timbers, Luke G. Atia, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5086-5086
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

TGF-β signaling: critical nexus of fibrogenesis and cancer
Anna O. Giarratana, Conor M. Prendergast, Mary Salvatore, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial
Anastasia E. Metropulos, Hidayatullah G. Munshi, Daniel R. Principe
EBioMedicine (2022) Vol. 86, pp. 104380-104380
Open Access | Times Cited: 48
Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade
Jie Mei, Yun Cai, Rui Xu, et al.
Cancer Communications (2024) Vol. 44, Iss. 5, pp. 554-575
Open Access | Times Cited: 13
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
Shivan Sivakumar, Ashwin Jainarayanan, Edward Arbe-Barnes, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer
Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005491-e005491
Open Access | Times Cited: 29
The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
Rachel R. Tindall, Jennifer M. Bailey, Yanna Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer
Daniel R. Principe, Patrick W. Underwood, Sandeep Kumar, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Durre Aden, Sufian Zaheer, Himani Ahluwalia, et al.
Cell Biology International (2023) Vol. 47, Iss. 5, pp. 859-893
Open Access | Times Cited: 16
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
Hiroyoshi Tanaka, Takuya Nakazawa, Atsushi Enomoto, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 724-724
Open Access | Times Cited: 14
Dynamic dysregulation of Tenascin-X/Tenascin-C balance controlled by Transforming Growth Factor-beta leads to tumor cell proliferation during pancreatic carcinogenesis
Sophie Liot, Charlotte Schmitter, Perrine Mercier‐Gouy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer
Tenzin Passang, Shuhua Wang, Hanwen Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 2954-2967
Open Access | Times Cited: 3
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer
Zibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 722
Closed Access | Times Cited: 9
Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer
Maria Caterina De Grandis, Velio Ascenti, Carolina Lanza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12681-12681
Open Access | Times Cited: 8
miRNA in Machine-learning-based Diagnostics of Cancers
William Kang, Valentina L. Kouznetsova, Igor F. Tsigelny
Cancer Screening and Prevention (2022) Vol. 1, Iss. 1, pp. 32-38
Open Access | Times Cited: 11
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer
Stephen D’Amico, Varvara Kirillov, Oleksi Petrenko, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 2
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions
Thomas Enzler, Jiaqi Shi, Jake McGue, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2953-2953
Open Access | Times Cited: 2
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer
Stephen D’Amico, Varvara Kirillov, Oleksi Petrenko, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 2
The concomitant use of the renin–angiotensin system inhibitors and survival outcomes of patients with pancreatic adenocarcinoma: an analysis from a tertiary center
Kuan-Yu Tseng, Chiann‐Yi Hsu, Yu‐Hsuan Shih, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2
TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance
Allan M. Johansen, Steven D. Forsythe, Callum McGrath, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 17, pp. 3676-3687
Closed Access | Times Cited: 2
The Association Between Preoperative Sarcopenia and Sarcopenic Obesity and the Occurrence of Postoperative Complications in Patients Undergoing Pancreaticoduodenectomy for Periampullary Malignancies—A Literature Review
Jakub Ciesielka, Krzysztof Jakimów, Karolina Majewska, et al.
Nutrients (2024) Vol. 16, Iss. 20, pp. 3569-3569
Open Access | Times Cited: 2
A CNA-35-based high-throughput fibrosis assay reveals ORAI1 as a regulator of collagen release from pancreatic stellate cells
Rieke Schleinhege, Ilka Neumann, Andrea Oeckinghaus, et al.
Matrix Biology (2024) Vol. 135, pp. 70-86
Open Access | Times Cited: 2
Sparstolonin B inhibits pancreatic adenocarcinoma through the NF-κB signaling pathway
Yang Lyu, Bowen Duan, Ziming Liu, et al.
Experimental Cell Research (2022) Vol. 417, Iss. 1, pp. 113214-113214
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top